Vanguard Group Inc Coh Bar, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$0.17 - $5.25 $341,665 - $10.6 Million
-2,009,796 Closed
0 $0
Q2 2022

Aug 12, 2022
SELL
$0.17 - $0.34 $455 - $910
-2,678 Reduced 0.13%
2,009,796 $381,000
Q4 2021

Feb 14, 2022
SELL
$0.34 - $1.0 $3,591 - $10,563
-10,563 Reduced 0.52%
2,012,474 $705,000
Q3 2021

Nov 12, 2021
BUY
$0.96 - $1.62 $7,108 - $11,996
7,405 Added 0.37%
2,023,037 $1.94 Million
Q2 2021

Aug 13, 2021
BUY
$1.09 - $1.49 $2.2 Million - $3 Million
2,015,632 New
2,015,632 $2.82 Million

Others Institutions Holding CWBR

# of Institutions
1
Shares Held
1.14K
Call Options Held
0
Put Options Held
0
View Full List

About CohBar, Inc.

CWBR Quotes by TradingView
  • Ticker CWBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,906,940
  • Market Cap $1.28M
  • Description
  • CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...
More about CWBR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email